Adam Morgan is currently serving in various leadership roles in several companies, including Alimera, Velan Capital, and Heron Therapeutics, Inc. With a background in finance and healthcare, Adam has held positions such as Chairman of the Board, Director, and Managing Member and Chief Investment Officer. Adam's extensive experience also includes roles in sales, technology management, and product management in companies like BIOTRONIK and American Medical Systems. Adam holds an MBA from the University of Minnesota - Carlson School of Management and a B.S. in Chemistry from the University of Minnesota.
August 1, 2023 - present
March, 2023